Selank 10mg Research Peptide
A synthetic heptapeptide analog of the immunomodulatory sequence tuftsin, studied for its regulatory role in stress signaling.
View Certificate of AnalysisFor Research Use Only (RUO) · Not for human or veterinary use · Delivery in 4–5 business days
A synthetic tuftsin analog engineered for stability.
Selank was developed at the Institute of Molecular Genetics of the Russian Academy of Sciences as a synthetic analog of the endogenous peptide tuftsin. By extending the native sequence with a stabilizing fragment, researchers produced a molecule with markedly improved resistance to enzymatic degradation compared to the parent compound.
In the research literature, Selank has been examined for its influence on the balance of monoamine neurotransmitters and on the expression of brain-derived signaling factors. Its tuftsin lineage also places it within investigations of immunomodulation, where the parent sequence is known to interact with macrophage activity.
CellTheory supplies Selank as a lyophilized research peptide, characterized by HPLC and confirmed by mass spectrometry, with a batch-specific Certificate of Analysis provided for every lot.
Research Applications
Neuropeptide Signaling
Studied within models exploring monoamine regulation and stress-response pathways.
Immunomodulatory Lineage
Derived from tuftsin, a fragment associated with innate immune signaling in the literature.
Stability Profiling
Used to compare enzymatic resistance of modified versus native peptide sequences.
Independently Tested.
Verified by Batch.
Batch CT24-SEL-014
Questions.
Selank is supplied as a lyophilized (freeze-dried) research compound in a sealed glass vial containing 10mg. It is intended strictly for in-vitro laboratory research and is not for human or veterinary use.